Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Acetyl-Carnitine and Reduced Pain

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects of acetyl-carnitine on pain reduction, with effect sizes ranging from small to moderate. The evidence is preliminary and predominantly from clinical populations with sciatica or carpal tunnel syndrome, using doses around 1000 mg/day. Effects were observed over a median study duration of 45 days.

  • Effective dose range: 600-1000 mg/day
  • Studied populations: patients with sciatica, patients with mild to moderate carpal tunnel syndrome

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Two of the three studies used acetyl-carnitine as part of a combination product, so isolating the specific effect of acetyl-carnitine alone is difficult.

Generated Jun 13, 2026
Doses used in studies
  • mg/day: 1,000–1,200 (median 1,100, IQR 1,050–1,150) — 2 studies
Time to effect
Median: 6.4 weeks · IQR 5.4 weeks–7.5 weeks · Range 4.3 weeks–8.6 weeks — Reported in 2 of 3 studies
Safety in these studies
3 of 3 papers
Back to top